— Research note —
Epitalon (Epithalon)
Synthetic tetrapeptide developed in St. Petersburg investigated for pineal gland-related signaling and telomerase regulation in preclinical aging research.
Epitalon (Epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology in the late 1980s. The molecule was designed as a synthetic mimetic of the natural peptide preparation Epithalamin, an extract derived from bovine pineal gland tissue that was characterized in earlier Soviet-era research as having effects on neuroendocrine regulation and lifespan in rodent models.
The peptide has been investigated in a research program spanning more than three decades, with publications from the Khavinson group and collaborators examining effects on telomerase activity in human somatic cells, melatonin secretion, circadian rhythm parameters, and lifespan in rodent models. The peptide is one of the most extensively studied short bioregulatory peptides from the Khavinson Russian school of bioregulation, a research tradition that has generated multiple short peptides claimed to engage tissue-specific epigenetic regulatory mechanisms.
In preclinical research, epitalon has been observed to extend median and maximum lifespan in mice and rats in some studies, to increase telomerase activity in cultured human somatic cells, and to modulate melatonin secretion from pineal preparations. The mechanistic basis for these effects has been proposed by the Khavinson group to involve direct interaction with DNA promoter regions, an unusual mechanism for a small peptide that remains incompletely characterized in independent peer-reviewed studies.
Epitalon is supplied here for laboratory research use only and is not intended for human consumption. Researchers should note that the primary research literature on the compound is concentrated within the Khavinson group and collaborating Russian institutions, with independent replication of key findings in additional jurisdictions representing an important area for continued investigation.
Mechanism
The proposed mechanism of action of epitalon has been described by the Khavinson group as involving direct DNA binding at specific promoter regions, with consequent modulation of gene expression. Reported effects on telomerase activity in cultured human somatic cells, including human fibroblasts and lymphocytes, have been attributed to upregulation of the TERT catalytic subunit promoter. This proposed mechanism is distinctive among bioactive peptides and remains incompletely characterized in independent peer-reviewed studies outside the Khavinson research program.
Additional reported effects include modulation of melatonin secretion from pineal gland preparations, suggesting an action on pineal endocrine function. In rodent studies, the peptide has been associated with normalization of circadian rhythm parameters and with extension of median and maximum lifespan in some experimental designs. The relationship between proposed gene-regulatory effects and observed physiological phenotypes remains an active area of research interpretation, with continued characterization needed to integrate molecular and organismal observations.
Research history
The Khavinson research program at the St. Petersburg Institute of Bioregulation and Gerontology emerged from earlier Soviet-era investigations of organ-derived peptide extracts with claimed bioregulatory activity. Epithalamin, the bovine pineal gland extract, was characterized in publications from the 1980s reporting effects on neuroendocrine function and lifespan in rodent models.
Epitalon was developed as a synthetic mimetic of the active component of Epithalamin and entered preclinical research in the late 1980s and 1990s. Publications from the Khavinson group through the 2000s and 2010s reported effects on lifespan in mice and rats, on telomerase activity in cultured human cells, and on melatonin secretion. The proposed direct DNA-binding mechanism was advanced in publications examining peptide-promoter interactions.
The body of independent research on epitalon outside the Khavinson program and collaborating institutions remains modest, an important consideration in interpreting the literature. The compound has nonetheless been included in research-chemical catalogs and has been used as a tool molecule in aging research and short-peptide pharmacology studies. Continued independent investigation, particularly of the proposed DNA-binding mechanism and of lifespan effects in standardized aging-research models, represents an area of interest for the broader peptide research community.
References
- Khavinson VK. 2002. Peptides and Ageing. Neuro Endocrinol Lett. PMID: 12374906
- Khavinson VK, et al. 2003. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. PMID: 14534633
- Anisimov VN, et al. 2001. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int J Cancer. PMID: 11774290
- Khavinson VK, Morozov VG. 2003. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. PMID: 12973134
- Anisimov VN, Khavinson VK. 2010. Peptide bioregulation of aging: results and prospects. Biogerontology. PMID: 19957062
- Khavinson V, et al. 2014. Peptide regulation of gene expression: a systematic review. Molecules. PMID: 24566313
Do you have any questions about Epitalon (Epithalon)?
Pick a path. The research assistant has the full literature context loaded.
Information presented in third-person scientific context. Research use only. Not medical advice; not for human consumption.